On March 10, the US Department of Health and Human Services (HHS) announced that newly confirmed HHS Secretary Robert F. Kennedy Jr. has ...
The U.S. Food and Drug Administration will step up its testing for heavy metals in infant formula and review nutrients ...
With companies constantly developing new therapies and technologies, the biotech industry is a hotbed of innovation. This dynamic environment ...
The effort, dubbed “Operation Stork Speed,” aims to ensure “quality, safety, nutritional adequacy, and resilience” of infant ...
The Department of Health and Human Services, alongside the Food and Drug Administration, launched a new initiative Tuesday ...
4h
Zacks Investment Research on MSNFDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for ReviewDr. Reddy’s Laboratories RDY and partner, Alvotech ALVO, announced the FDA’s acceptance of a regulatory filing, seeking the ...
4h
Zacks Investment Research on MSNJNJ's Nipocalimab Gets FDA's Fast Track Tag for Sjogren's DiseaseJohnson & Johnson JNJ announced that the FDA has granted a Fast Track designation (“FTD’) to its investigational drug, ...
The latest trend in treating hair loss may sound familiar — essentially, it’s a repurposed drug first popularized in the ...
The US Food and Drug Administration (FDA) has launched “Operation Stork Speed” to enhance oversight of the infant formula.
Health and Human Services Secretary Robert F. Kennedy, Jr., has turned his attention to infant formula, with the goal of ...
Despite the Trump administration's shake-up of the agency, the US FDA is the first port of call for most ASX biotechs.
The Food and Drug Administration (FDA) announced a new initiative Tuesday titled “Operation Stork Speed” aimed at reviewing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results